Details
Stereochemistry | ACHIRAL |
Molecular Formula | C26H30F2N6O |
Molecular Weight | 480.5528 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)N1CCOC2=C(F)C=C(C=C12)C3=NC(NC4=CC=C(C=N4)C5CCN(C)CC5)=NC=C3F
InChI
InChIKey=YZSCPLGKKMSBMV-UHFFFAOYSA-N
InChI=1S/C26H30F2N6O/c1-16(2)34-10-11-35-25-20(27)12-19(13-22(25)34)24-21(28)15-30-26(32-24)31-23-5-4-18(14-29-23)17-6-8-33(3)9-7-17/h4-5,12-17H,6-11H2,1-3H3,(H,29,30,31,32)
Molecular Formula | C26H30F2N6O |
Molecular Weight | 480.5528 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:57:50 GMT 2023
by
admin
on
Sat Dec 16 15:57:50 GMT 2023
|
Record UNII |
Q6460P4C0B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
805820
Created by
admin on Sat Dec 16 15:57:51 GMT 2023 , Edited by admin on Sat Dec 16 15:57:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Q6460P4C0B
Created by
admin on Sat Dec 16 15:57:51 GMT 2023 , Edited by admin on Sat Dec 16 15:57:51 GMT 2023
|
PRIMARY | |||
|
2370913-42-9
Created by
admin on Sat Dec 16 15:57:51 GMT 2023 , Edited by admin on Sat Dec 16 15:57:51 GMT 2023
|
PRIMARY | |||
|
12222
Created by
admin on Sat Dec 16 15:57:51 GMT 2023 , Edited by admin on Sat Dec 16 15:57:51 GMT 2023
|
PRIMARY | |||
|
300000047413
Created by
admin on Sat Dec 16 15:57:51 GMT 2023 , Edited by admin on Sat Dec 16 15:57:51 GMT 2023
|
PRIMARY | |||
|
139390026
Created by
admin on Sat Dec 16 15:57:51 GMT 2023 , Edited by admin on Sat Dec 16 15:57:51 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
IN-VITRO, IN-VIVO
|
||
|
TARGET -> INHIBITOR |
IN-VITRO, IN-VIVO
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|